High-Sensitivity Next-Generation Sequencing MRD Assessment in ALL Identifies Risk of Relapse
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
High-sensitivity next-generation sequencing MRD assessment in ALL identifies patients at very low risk of relapse
Blood Adv 2022 May 09;[EPub Ahead of Print], NJ Short, HM Kantarjian, F Ravandi, MY Konopleva, N Jain, R Kanagal-Shamanna, KP Patel, W Macaron, TM Kadia, SA Wang, JL Jorgensen, JD Khoury, M Yilmaz, P Kebriaei, K Takahashi, G Garcia-Manero, NG Daver, SM Post, X Huang, SM Kornblau, S Pelletier, W Flores, J Matthews, R Garris, EJ JabbourFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.